Newman David J, Cragg Gordon M
NIH Special Volunteers, Natural Products Branch, National Cancer Institute, Frederick, MD, USA.
Planta Med. 2016 Jun;82(9-10):775-89. doi: 10.1055/s-0042-101353. Epub 2016 Feb 18.
The potential of the marine environment to produce candidate compounds (structures) as leads to, or even direct drugs from, has been actively discussed for the last 50 or so years. Over this time frame, several compounds have led to drugs, usually in the area of cancer (due to funding sources). This review is designed to show where there have been successes, but also to show that in a number of disease areas, there are structures originally isolated from marine invertebrates and free-living microbes that have potential, but will need to be "adopted" by pharmaceutical houses in order to maximize their potential.
在过去约50年里,人们一直在积极讨论海洋环境产生候选化合物(结构)以作为先导物甚至直接开发成药物的潜力。在这段时间里,有几种化合物已开发成药物,通常是在癌症领域(由于资金来源)。本综述旨在展示取得成功的地方,同时也表明在许多疾病领域,有一些最初从海洋无脊椎动物和自由生活微生物中分离出来的结构具有潜力,但需要制药公司“采用”才能最大限度地发挥其潜力。